Introducing the Payerset Research Assistant
The Price of Healthcare Podcast cover art
Season 1 · Episode 6 · · 70 min

What an anesthesiologist finds when he reads employer claims line by line

with Steve Borene, Co-founder and CEO, Renovo Health

0:00 / --:--

Dr. Steve Borene is an anesthesiologist, a Marine Corps veteran, and the co-founder and chief executive of Renovo Health, a direct-pay surgery and medical infusion center in Wisconsin. With more than 20 years in practice, roughly 80,000 anesthetics behind him, and a master’s degree in healthcare delivery science from the Tuck School of Business at Dartmouth, he reviews employer claims line by line and rebuilds them into full episodes of care so employers can see what they paid for.

Employer claims data lists care code by code, so a single surgery or colonoscopy can appear as several separate charges spread across different dates and providers. This conversation focuses on what those codes leave out, from duplicate procedure charges and pathology billed days later to routine medications billed as expensive infusions. Steve explains how grouping every charge by patient and date of service shows the true cost of each episode, and how Renovo sets its own bundled prices from the cost of goods sold, the way most other businesses do. Listeners walk away knowing where waste tends to hide in claims data, how much of it an employer can cut, and what employers, brokers, and physicians can do about it.

In this episode

  • How one county’s 74 colonoscopy claims add up to only 28 patients once every charge is bundled by patient and date, at about $15,800 per patient
  • What those same 28 cases would cost at Renovo: $84,000 instead of the $444,000 the county paid
  • Why Zofran (ondansetron), which costs Renovo about 50 cents a dose, can show up on a claim as a $1,200 infusion, and why the coding rules leave room for it
  • Why 10% to 15% of the employer spend Steve reviews is typically waste, and how the same county expects to cut about $2 million from $13 million in annual claims
  • How Renovo sources an infusion drug for about $14,000 that previously cost $83,000, then adds an infusion fee of about $1,500, saving one employer about $85,000 twice a year on a single employee
  • Why Renovo’s polyp rate runs near 100% for repeat colonoscopy patients, and how a polyp can turn a free screening into a $12,000 bill when Renovo’s own added cost is about $140
  • How a pediatric dental case that grew from five restorations to nine strengthened Renovo’s relationship with an employer
  • How non-compete agreements in Wisconsin kept two physicians from joining Renovo and slowed its growth by several months
  • How physicians can ease into direct care through part-time schedules, locum tenens work, or a gradual move away from insurance

Transcript

Andrew Gordon: Welcome to The Price of Healthcare. I’m your host, Andrew Gordon. On this show, we sit down with the executives, influencers, and people working to build a functional healthcare market. Every episode, we’re unpacking what’s broken, what’s working, and what it takes to buy healthcare with informed choice.

Andrew Gordon: My guest today is Dr. Steve Borene. Steve is an anesthesiologist with more than 20 years in practice and the co-founder and chief executive of Renovo Health, a direct-pay surgery and medical infusion center in Wisconsin that he built with his partner, Josh Johnston, who is also an anesthesiologist.

Andrew Gordon: Renovo posts its prices, bundles them, and holds them across general surgery, gynecology, urology, interventional pain, gastrointestinal procedures, dental restorations, and infusions. Before medicine, Steve served in the Marine Corps. He earned his medical degree at the University of Minnesota, completed his anesthesiology residency at the University of Iowa, and earned his master’s degree in healthcare delivery science at the Tuck School of Business at Dartmouth.

Andrew Gordon: He also runs an anesthesia staffing company, and he co-leads the Wisconsin chapter of the Free Market Medical Association. What got my attention is that Steve does not just quote a price. He reads an employer’s claims line by line and tells them what actually happened to their people.

Andrew Gordon: Steve, welcome to The Price of Healthcare.

Steve Borene: Thanks, Andrew. I appreciate that. I appreciate the opportunity.

Andrew Gordon: You talked about reading pathology reports and other things, and I don’t know how much people know about your skill set in terms of reading claims data and the unique area that you sit in. So I want to get into some of what you’ve been able to see inside the claims data that you’ve reviewed.

Andrew Gordon: We can even start with the anti-nausea medicine that was billed as an infusion for $1,200. You figured out that happened. Talk to us about that and what that charge should have been, and walk us through some examples there.

Steve Borene: So that’s the problem, and that was one of the things that initially connected us up as well, too. One of the advantages of working for decades at anything, I imagine, is you become expert at something. You have to become expert at something.

Steve Borene: That’s what I always told my kids, too, and I still tell them, it doesn’t matter what you do. Become an expert at something. And then you’ll always be worthwhile, you’ll always be able to make a living, you’ll always be able to contribute, you’ll always have something to fall back on.

Steve Borene: And the things that I became expert on are the same things that so many other people in my role are. I am in the operating room. When I talk to a patient, I have to find out information that’s happened previously, whether it be lab work, whether it be imaging, whether it be their lifestyle, whatever their health condition is, and the things that the health system has done for them before.

Steve Borene: And I’ve got to plan for how this is going to, what my interaction is going to do to alter that or maintain it in a way going forward. So that also means what kinds of care are going to happen a day later. An example there is pathology. So the pathology may not get evaluated for another day or two, right? So that’s a different component. So I’m doing something so that two days from now, the pathologist can have some tissue reading that’s going to play a role.

Steve Borene: So we’re maybe gathering things. So we can’t look at what I’m doing as an event, right? We do, and we work with a group that reports them as episodes of care. And I think most people go through life, it’s an episode of care, whether you’re replacing a toilet or you’re seeking healthcare, right? We bundle things together. We combine them.

Steve Borene: If you go to the hardware store, you get almost everything you need for your new toilet. You go home and you’re missing one thing. You go back, you don’t think that’s a new visit. You don’t think the second trip to the hardware store, and we’ve all made that second or third trip to the hardware store, and then you’re like, I recognize her, she’s still behind the counter, and she’s going to wonder why I don’t know what I’m doing. That’s still one trip. You might have done three trips back and forth, but you got three receipts when you’re all done. It’s because you failed somewhere along the line to put those together. But those are all part of the same episode, which is fixing the toilet.

Steve Borene: Healthcare is actually the same way as fixing the toilet in many ways, right? Somebody comes in and they need their gallbladder removed, and they’ve got a hernia they need to repair. They come in. As part of that, they need to, sure, take time off of work and get somebody to transport them there. They need to pay for the fuel to get there. They need to walk in the door. We need electricity. We need to be accredited so we can show everyone that we’re professional. We have licenses. We need an IV. We need fluids. We need medications. We need a surgeon that’s adept at doing these procedures. We need that equipment. We need the lights. You build all that together.

Steve Borene: And when we do that, we come up with a price. When people are looking at claims data, a lot of those touch points within the legacy systems get a code. They get put into a claim. And some of the medications, IV fluids, get included. When you’re looking in medications, anti-nausea medicine we talked about, pathology, professional fees for a gastroenterologist and the anesthesiologist and the pathologist and the pathology reading, all that gets put in. If you’re looking at claims data, and you say, we had this many gallbladders, and it cost us this much, but that’s all you look at is the code. You miss that they also had this medication, and they also had this pathology report, and they also had this anesthesiologist. You got to put all that together. Well, that gets complicated real quick.

Steve Borene: I’ll use colonoscopy as an example. One of the counties that we work with and we’re saving, I expect their claim spend for year two of working with, or when they’re working with us, so year one is when they got on board with us. We’re going to end up knocking their claim spend down by about 15%. Their $13 million a year spend is going to go down by about $2 million. And when I first talked to them, let me see, I have the numbers here. What did they do? Colonoscopies. They had 74 colonoscopies at $6,000 each. So I thought, wow, for your group, that’s an awful lot. For the number of covered lives you have, I wouldn’t expect that many. This is interesting. Let’s look into it.

Steve Borene: So I got their claims data, and I looked at it, and I saw patient identifiers, and I combined that with the date of service. So I bundled everything that happened on that date of service, and I noticed that typically they had three colonoscopy charges for each patient on that day of service. And so one, they were getting a screening colonoscopy, but then they’d also have biopsies or different levels of polypectomies. A lot of these groups that were, or a lot of these patients were having multiple charges. Included in those visits was also medications. There was also pathology, but pathology wasn’t always on the same day. It might be two or three days later, like I had mentioned. So it wasn’t just a matter of me looking and saying, what’s all the care this patient received this day cost? Well, it turns out they only had, I think it was 28 actual cases.

Steve Borene: So they had paid $444,000. They thought they did 74 colonoscopies. They only had 28 actual cases. So they did on average $15,800 for each colonoscopy patient that came in. They wouldn’t know that if they looked at the line, the machine readable data comes across and says, this is how many people you got taken care of. And this is all you paid. And their broker says, wow, this is great. And they’re going, wow, we’re pretty good. They’re patting themselves on the back.

Steve Borene: Well, I go back and I say, boy, you guys are going to not like this. But if you would have come to Renovo for those same number of patients, it would have been $84,000 instead of $444,000 because you only did 28 cases. And by the way, all these other costs were included in the care that you aren’t even attributing. You’re just paying that. And they’re blown away, right? So that happens all the time.

Steve Borene: I typically find two or three procedures billed, often at a lower cost. So the first one comes across maybe at $9,000, but then they have two more at $3,000. All right, we just managed to get $15,000 out of something that should have been three with us, right? And then they’ll counter, right? So that’s where it’s important to get into the data. And this one particular county had 36,000 lines of data. So I went through them all, tried to be as efficient as I could using all the different tools within the Excel sheet. And I was able to bundle things. I added the things that were put in from other dates that were also tied in with that, which I can only do because I know what the patients get before, during, and after.

Steve Borene: That’s what I found. Zofran is the medication. If you do an infusion of Zofran, you can bill $1,200. I’ve given Zofran, I would guess, 50,000 times in my career. I’ve done about 80,000 anesthetics in my career. Most of them get Zofran. It’s a good medication. It’s an anti-nausea drug, ondansetron. I just double-checked to see how much it cost me at Renovo. I can get 25 vials of it. So four milligrams of the medication is a standard dose. I can get 25 vials for $11.66, so about, what is it, 50 cents per application, injection.

Steve Borene: If I were to take that medication, draw it out of the syringe, put it into an IV bag, run it through an infusion system, and bill for that, it’s a $1,200 charge. In this particular county, I found multiple instances where they paid that $1,200 charge for that medication. In the 50,000 times I’ve given that medication, or ordered it, probably more than that, I’ve probably ordered that medication or given it a quarter million times in my career. Never once has it been through an infusion. They might give it over a few minutes, but what happens in the medical chart is somebody puts that they infused, sometimes they’ll put they injected the medication, or it’s given IV.

Steve Borene: Somebody could read that as being infused, because technically it’s an infusion, whether you put it through the syringe or through, there’s no difference. There’s a reason that there’s a different code is it’s supposed to indicate this other instance. Nobody can come back after the fact and prove that they didn’t do it the other way. Somebody who’s trying to get an extra $1,199.50 would intentionally put that in. I’m not saying that those coders intentionally put that higher number in. I’m saying that they don’t know the difference and that somebody knows this is going on and they’re not correcting them. So there’s something more than just wrong. There’s something fishy, but either way, there’s waste and abuse going on here, right? So I found that several times in just that one county.

Steve Borene: So that’s the danger of going to a system where they give you so much data. They fill 36,000 lines with their healthcare spend, and they just paid the number that comes across. This is a bill for $1,200. They paid it. It was a separate bill.

Steve Borene: That’s one of the things that I offer for any of the employers, and it’s exhausting, but it’s really fun. It’s detective work. I offer, I tell them, give me your data. I will go through and I’ll show you, anyone who’s prospective to work with us, how much will you save? And that’s where I come up with this 15% number because every group I’ve gone through, it’s been around 15%. Now, the caveat to that is 10% to 15% of everybody’s spend that I’ve evaluated has waste and fraud in it and stuff they shouldn’t have paid.

Steve Borene: So I’ve offered, and we’ve done this with one group, it’s been really good because they’re smaller and I can do it myself, to go through and they’ve been providing me with their data. They’re no longer paying right away. They’re waiting for the end of the month and they’re providing me with the data, and I’m going through and I’m like, don’t pay this one. Don’t pay this check. Refuse to pay this one. And they’re currently having a bit of a falling out with their TPA, which they’re going to switch at the new year because they’ve got another TPA that we’ve worked with and had good success. But they’re currently, and it’s really kind of fun because the head of human resources for that group, which happens to be a government entity, is having a lot of fun. He’s just poking the bear, getting back at these people because they shouldn’t have been paying it ever.

Steve Borene: But we’re able to find that by getting into the data, by having the expertise to put that all together, to attribute each episode of care, build that into a bundle, and then say, uh-uh, or this is wrong, or this is your apple to compare to another apple. And by getting into the minutiae based on that expertise and experience, we can show people that they’re typically wasting probably 10% to 15% straight up. That’s even if they made all the other right decisions on their care, 10% to 15%. They could reduce that by probably another 60% if they went to people that were already bundling and offering these services. I mean, it blows you away.

Steve Borene: It’s insane that people aren’t doing it, and it’s actually really bothersome to the people when they see this information. And they’re coming back to me, and they’re ready to hit somebody because they’ve been, this is who the crime’s been committed against. So I don’t know, a little bit of an all-around answer for you.

Steve Borene: But that’s where the data matters. Data in itself is nothing. Anyone can collect the data, but what are you doing with it? Are you compiling it into a way that it can be bundled or built into an episode, attributed to a patient, and then at that point, you can see where you’re wrong, where you’re right, and can you do something actionable with that? And that’s what we do, is we put all those pieces together to make it so that when these employers, and like I said, this one county, they’re going to save 15%, $2 million. That’s pretty cool for a county. It’s a county government who had never looked at that before.

Steve Borene: And the gentleman I work with there, he says, I just want to pay you. I want to pay the people giving the care. I don’t want to have to pay all these other people. Can I get rid of them? And the answer is getting closer and closer to, yeah. Yeah, you can do that. That’s pretty exciting. And that’s what we’re trying to do.

Steve Borene: And I don’t even remember what the question was, but that’s the answer.

Andrew Gordon: Data, delivery of care, and being in a position to be a decision maker. When I heard you speak, I put together all those dots there. You know how to read, interpret, use data. You deliver care every day, so you understand. See, there needs to be, when we’re looking at claims, you need to have a lot of different subject matter experts or folks that can tether those different angles together.

Andrew Gordon: And I would imagine, too, just as an extension of your background in the Marines and being able to be a jack of all trades in some regard or be able to navigate and survive environments on your own in the way that you’re trained to think and disciplined to act. I feel, in a similar way, bringing that into the healthcare domain with what you’ve been able to do, the fact that you can look at claims, you do deeply understand delivery. You are in a position of great accountability and responsibility with your own practice to make decisions on suppliers and other things there.

Andrew Gordon: And then we’ve had conversations where we’ve been talking and we hit pause because you’ve got to go answer the phone or you’re answering the phone to help schedule somebody. And it goes back to those. See, I want people to hear this, Steve. And I want them to realize that there’s beauty in that. I don’t want people to say, oh, well, you know, he’s answering the phone. It must mean… The connection that you’ve told me that you’ve been able to have with patients by virtue of, oh, wait, you’re also going to be caring for me during the event and you’re answering the phone. And that special relationship that stems from that is truly extraordinary.

Andrew Gordon: Now, I do want to, I want to go back to something that you said relative to Zofran. That was a huge point on injection versus infusion. And I think the question a lot of us probably have is with that massive differential and delta in reimbursement between those two. Is there any reason why an infusion medically, clinically would be prioritized over an injection? Because I think a lot of us are trying to understand what’s the cause for some of that. And then is it also just the process of an infusion? Obviously, there’s more involved. There’s a little bit more at stake.

Andrew Gordon: But what benefits, I guess, said differently to Steve, what benefits would I be getting or would my family or friends or America be getting from receiving some medications and drugs? Because I imagine it’s not just with Zofran and anti-nausea stuff, but just in general, I’m sure there’s patterns here. What benefits are we receiving as patients taking infusions instead of injections?

Steve Borene: Right. Well, and for some medications, that’s the way they’re given. Your body needs to get them slowly over a period of time. And that’s so much of what we do in our infusion clinic.

Steve Borene: Today, in fact, the reason we had to, going back to your earlier point, the reason I had to reschedule us speaking today is because we had an infusion patient coming in that we had a little bit of an alteration of a schedule. So patient care, clinical duties are always going to take priority for me. And I appreciate your flexibility with that.

Steve Borene: And so there are instances where medications are given that way. And that’s the right thing. And that’s the only way that they can be given. But there are instances within the system that there’s the opportunity for something to be mis-billed. Right.

Steve Borene: Or on paper, if you came back to me and said, was this or was this not an infusion of Zofran in this case? Technically, it probably was. It fit the criteria for infusing, because I think infusing is probably just getting it into an IV line and running. So then maybe all I ever do is infuse medications. Right. How is that different from injecting, then? Maybe an injection would be if I just did subcutaneous or intramuscular and not intravenous. Right. So that’s not anything the system is set up to have clear. It’s as nebulous as can be. And that’s intentional. The system intentionally put that in there.

Steve Borene: I’m sure the reason it has its own infusion code. I don’t think anyone thought, well, what if you know, how are we going to keep track of this when we are giving this medicine? It costs 50 cents to actually give it. And you’ve already got all the same tools. The pathway is already there. The IV is already in place. So I don’t think the first person said, let’s go ahead and find a way to go ahead and get an extra $1,000 from this medication. I think somebody said, how do we go ahead and find a way so some nurse can justify what she did? Some tech can go ahead and keep track of what data is going on.

Steve Borene: You know, so it all comes from that. Let’s get more and more information. Somebody needed information. So they gave it a code and they said, this is what happened. This person was gone for five minutes because of this. Well, they didn’t connect up that it was already happening. Somebody didn’t know. And so now you’ve got two different things that mean the same thing, but cost something totally different. That gets into the system and there’s no incentive for anybody to stop it.

Steve Borene: Somebody along the line said, wait a minute, this can be lucrative. Nobody’s going to know. Let’s do it this way. Now, that was untoward. That was unethical, that somebody along the way did that. I’m guessing most of the people along the way don’t know that that’s what they’re even doing.

Steve Borene: I bet the coder that saw that multiple times on that one county, every time he or she sees that, enters it that way, thinking that that’s their job. They work in healthcare. They’re helping. They’re attributing something because it showed value and it must be valuable enough to justify that higher cost. I better include that. So they’re just doing their job. They don’t see either end of it.

Steve Borene: In the, like I said, I expect that I’ve given that medication or ordered that medication at least a quarter million times in my career. Never once in those instances would putting it in an IV bag and running it in over a period of time be useful. That’s not what the product package insert says. That’s not the way that it’s given. It’s given over a few minutes through a syringe. You give a little bit, then you give a little more. That technically is probably an infusion because it goes through an IV line. But that’s not what the medication costs. That’s not how people actually give it. Nobody sets up an IV tubing with an infusion pump to go ahead and give it over some period of time. That doesn’t happen.

Steve Borene: And that’s what the J code and the infusion code would have all meant to somebody initially. But that isn’t the way that it’s practiced. And because everybody along the way, except for the funder of healthcare, benefits from that, and the funder of healthcare doesn’t know and can’t see that, it’s never going to change unless we make everyone aware of it or make everyone aware of, you don’t want to go to that system because that’s the kind of stuff that slides through.

Andrew Gordon: For sure. And I do think the show is called The Price of Healthcare. And a lot of what you just described is the price of ignorance. And I think that there is certainly importance. If there’s something that this audience should take away from that last segment just there, Steve, it’s certainly being able to have a deep understanding of the end-to-end workflow. One of the things I like to share with people is that comprehension precedes creation. We must first understand if we look to build anew or if we look to open up new doors.

Andrew Gordon: When you stepped into this direct care world and you were meeting with folks, learning about it, using all the historical knowledge you had, then diving in and figuring this out, there’s amazing frameworks in what you’ve shared and how you’ve set up shop and what you’ve chosen to focus your time and energy and effort on that I think the audience could find certainly valuable.

Andrew Gordon: I do want to touch on the example you had said, and I think it was in an earlier conversation about an infusion drug you sourced for $14,000. You delivered it for $16,000. The claims file showed $83,000 for that drug alone. Tell us a little bit about that, about the delta between those numbers, how you decided you were going to offer it for $16,000 when you acquired it for $14,000. That’s a lot of capital that had to be locked up for your business and just in general the operation when you’re buying these drugs. How do you think through that?

Steve Borene: Well, it goes right back to the foundation we had before, cost of goods sold and being able to justify everything that we do. I can’t justify making a whole bunch of money off of medication that I didn’t invent, I didn’t develop, I didn’t deliver. I didn’t even deliver it to myself. All I did was take it from… our FedEx brought it to us, we put it in the refrigerator, we saved it until we started an IV, and then we put it in the patient. That’s what I want to get paid for. I want to get paid for the healthcare. I can justify paying for storing it in the refrigerator. I can justify the IV tubing, but I can’t justify making more off that infusion.

Steve Borene: That particular patient was paying over $100,000 for a medicine. I’ll give credit to the medication. It’s an amazing drug for some people. And credit to the employer. The employer has been paying this for years. They got millions of dollars spent on this guy. They are not making money off of him. They’ve got a huge investment. They love him.

Steve Borene: His company had been paying $103,000 or $105,000. They were sourcing the medication for $83,000 and they were pretty happy with, I won’t say the name of the group, but they were only charging $20,000 to infuse the medication. They could. I’m sure there’s somebody that’s given that medication for $200,000 or $300,000, not $100,000.

Steve Borene: But that company, they worked through another group and they said, hey, we just signed them on. They’re interested in seeing how much it would cost for you to get this medication. So I called four different suppliers. I checked with the easy one that’s on the computer. I did the emails and made some phone calls. It was, I feel like, $14,500 or maybe $14,300 for the medication that we were able to source. So instead of the $83,000, I was able to get it for $70,000 less.

Steve Borene: We told them that and they said, all right, well, how much would the difference be? I said, well, our standard price is, I believe it’s $1,508 for an infusion. Maybe it’s $1,506. I can’t remember the numbers. My nurses do the same thing.

Steve Borene: We had an Avsola infliximab infusion for a patient and our same bill is going to be the same, $1,506 or $1,508 to that employer. That particular patient, he was paying $6,000 every eight weeks to receive the medication previously, but it’s the only way that he could keep working. So he paid that himself. His employer was paying, I don’t know how much they were paying, but I believe they were paying the same. I think they split the cost as a compromise with him. Now the employer pays all of it. With the cost of the medication and the infusion, it’s much less than either of them was paying previously.

Steve Borene: But with this particular patient, we talked to him back and forth. We added our $1,500 fee and that plus the $14,000 was just over $16,000, $16,100, whatever it was. And so he comes back every six months saving that, what is that, 80, wow, yeah, $85,000 twice a year for one employee that they’re saving, right? So that’s pretty significant.

Steve Borene: That same medication was up, I had a meeting and I think we talked about this with the county that we were talking about earlier. They wanted to know if we should do infusions through the system that was set up through their whole team or if they wanted me to just do the sourcing. It’s a lot of work for me to do it. I’m reaching out to a bunch of people and I don’t make any money doing it. So it is a little bit of a hassle for me to do. I don’t mind doing it because we’re helping people a lot. But I don’t want to be in the habit of doing that all the time.

Steve Borene: I said, all right, let’s get a couple of medications. Give me an example of what it is that we’d look at the cost difference. And this is when I found out that this is the drug supplier for that other group that we worked with because they said, well, how much would you get? They said, our most expensive one’s $83,000 that we’re seeing in this group. How much do you think you could get that for? And I knew that right away. I said $14,000 and they couldn’t believe it. And that’s when I said, hey, I bet you guys used to supply to these people. This is who we’ve got now. And I could see the gears moving in their heads. They were able to see why they lost one of their business people or their clients.

Steve Borene: Because it’s that simple. It’s just a matter of getting it out to people and then doing something about it. Because I have met with other businesses that have still worked with that other group. They said, just do it. That’s what we’ve always done. It’s too complicated. Or we’re going to have to get on the phone and call you each time because it’s hard. Because we aren’t an easy button. We can be an easy button once you get going. And we’re a worthwhile button.

Steve Borene: And if you want to save $2 million a year, that county could go ahead and hire somebody or however much a million dollars would buy. And they could just have a team that does nothing but sit and wait on the phone to call me. They could still afford to do that now. So it’s a matter of putting the resources into the place that it can actually help you.

Steve Borene: So that’s what happens when you look into it. That’s what happens when you evaluate the claims data and it means something. That’s what happens when you get that data back to the people who are funding and writing the check. And that’s what happens when those people who are funding the check realize they cannot write some of them. They can write a different number in. And it makes a difference.

Steve Borene: So you want to talk about affecting the cost, the price of healthcare. That’s where it happens. Get the data. Do something with the data. And make sure that something affects how people seek care. It’s all about healthcare delivery.

Andrew Gordon: Going into colonoscopies. And you had initially, I think, modeled to expect maybe about 40% of people would have polyps in terms of the cases and folks that you see. You’re finding that or there’s been times or instances where it’s run north of 90% of people that you see that have polyps. I’m interested and would love for you to share with the audience a little bit on why is your rate so high?

Steve Borene: Sure. So in building anything, in building costs and prices the way that we do, it’s based on costs of goods sold. So just like you would at the hardware store or the gas station. Any business, your business, that’s how you did it. How much do I have to make for my service? How much do I need to bring in? Because how much is it costing me? Hospitals don’t do that. Healthcare doesn’t generally do that. We thought it’s what the capitalist system is built on. Let’s see if it works. And it does.

Steve Borene: And so as part of that cost, we had to say, all right, how much is a polyp? If you go in and you don’t have a polyp, you might pay $5,000 or $6,000 for your colonoscopy if they don’t find one, if you go into a legacy system hospital. But commonly, people then end up with a $12,000 or $15,000 bill if they do.

Steve Borene: In fact, a lot of people have health plans where if you get the screening colonoscopy and it’s normal, you don’t pay anything out of your own pocket. What they don’t realize is if they have a positive Cologuard, which now it’s no longer screening, they have to pay for it. Or if they remove a polyp or take a biopsy, it moves to a different code, right? And now that’s $10,000 to $15,000.

Steve Borene: The most we’ve ever had anyone admit to paying is $18,000. He had a hot snare, cold snare, a real complicated colonoscopy. He was told follow up in a year. And three years later, his wife introduced him to us. We did the same thing, hot snare, cold snare. Ended up being a pretty complicated procedure. He got the $3,000 bill, right? So he had to take a second job. He changed all the things he did. He put off his care. He put himself at risk for cancer because his actual comment to me was it would be cheaper for me to get colon cancer than for me to have to go get another colonoscopy because of what they did, how they moved things around, right?

Steve Borene: So with colonoscopies, we figured we’d have about 40% polyp rate because that’s what’s reported in the literature. That’s what you should expect. Most people don’t have polyps, but almost half do. And people, once they have polyps, they tend to produce more of them.

Steve Borene: So what has happened is people would go in, they would be 46 years old or old guidelines were 50. They were 50 years old. They did all the right things. They went in for their free colonoscopy. They came out of that with some polyps that told them they have to come back for your repeat in five years and a $12,000 bill. They thought they were going in for free. They thought they did everything right. They were getting patted on their back. They were good, responsible husbands and wives and wage earners. They did all those things right and they got a huge bill.

Steve Borene: Well, they don’t go back. They say, forget this. This isn’t worth it. The one that the polyp they took off wasn’t pre-cancerous. I don’t think it’ll be a problem. Maybe I can go 10 years. Maybe I’ll go back eventually, but I’ll wait till Medicare age. I’ll wait. I’ll wait till my new plan or wait till I get a different employer.

Steve Borene: Well, these people have waited long enough. Their employer got involved with us and now they can come to us. Or a lot of them, they came to us and they said, hey, you’re not going to tell my employer if we come to you, right? Of course not. But we think your employer would like to know. They’re like, no, my employer is going to make me stay in network. I’m going to have to go into their network. And then if they find polyps again, which I think they will, because they’ve already found them in me before, then I’m going to have to pay the difference.

Steve Borene: So those are people that came into us, especially at the beginning and paid cash. We’ve got two patients that are paying cash who are people who fit this bill exactly, who have told us we don’t want our employer to know because the last time I went in, they found out and I went to the place they told me to and I had to pay.

Steve Borene: So we end up having all those people. Everybody who’s been burned before, they come in to see us. So we have a selection bias in our group. We have people that come in, if they’re first time colonoscopy patients, we see a 40% rate. But for people who’ve had a repeat, we’re almost at 100% because they’re all people who went to the other system and got burned.

Steve Borene: Now we’ve been doing this long enough. We’re starting to see some people come in who have had clean colons before and now their employers are sending them and they just happen to come through to us. So I think over time we’ll get closer, but we’re always going to be higher because not everybody subscribes to what we’re doing and those patients will find us. But yeah, I remember the very first polyp-free colonoscopy we got.

Steve Borene: And what’s interesting too, right, it costs us about an extra 140 bucks to take that, use the snare to go ahead and remove that, put it in the trap, the little jar, send it off to the same place that the hospital sent it to. Everybody sends it to Quest Diagnostics. Almost everybody in the country does. We send it to the same place as the hospital right up the road from us does. And it costs us about 140 bucks up to five. And then I think it’s $180 if it’s more than five. But we included that in our price of our colonoscopy.

Steve Borene: So I’d rather people come in and not have any. I can actually make $140, $180 for the procedure more than I would otherwise. Yet if I recoded it at those other systems, I’m going to add thousands of dollars onto it. There’s no reason why the legacy hospital should make a thousand or thousands of extra dollars. And what do you think that gastroenterologist is going to want to do? He’s going to want to make sure that he… anything, that’s normal tissue. I’m going to take a biopsy of it. We don’t have to worry about that. That’s the difference in care.

Steve Borene: If we look at it and our gastroenterologist says, no, I don’t think that’s anything. We don’t need to get that tissue, which always has a little bit of danger of perforating the bowel. If we can avoid that, we want to do that. Likewise, we don’t have the pressure to go ahead and take it or not take it, right? We can just do what’s best for the patient. My gastroenterologist doesn’t get paid more or less if they do or don’t take polyps. So they go through, they do what’s best for the patient.

Steve Borene: And it’s going back to the point about aligning with what’s best for people. That’s better for the patient. It’s better for the funder. It’s better for the physician because they’re actually doing what they want, which is to take good care of people. We just aligned all the people up.

Andrew Gordon: Operating and firing on all cylinders. And what you did there too, Steve, is you answered at least the million dollar question for me and something that I’ve always been curious about, which is, what is the differential on a colonoscopy that is a pure screening versus one that involves and includes a polyp removal? What does that delta look like? How much money is being made when there’s a differential in terms of the actual delivery of the service itself and what’s involved?

Andrew Gordon: And I think there’s a really good example for people who are listening to just understand this is general expectation of, because a lot of folks get surprised by the bill being diagnostic versus they, like you said, they went in and it was going to be covered. And so it’s incredible that we have these screenings and work that gets done that, hey, it’s covered. Hey, we get this. But then all of a sudden, the moment that polyps enter on the scene where there’s the most value possible from a healthcare perspective to help that individual, all of a sudden we’re seeing astronomical markups or pricing that goes far beyond what we were originally thinking is this screening. Let’s get you in the door.

Steve Borene: Yeah. And that’s really a really ugly part of healthcare, right? They will use incentives to get people in free and this is going to help you and we’ll be able to… it’s better for your health. Things that are all true. They’re able to use that in a setting where they’re tempting people or tricking people into thinking that they’re doing all the right things and they’re going to be a better employee because now you’ve proven that you don’t have cancer or we’ve been able to prevent a cancer and now you’ll be able to work longer.

Steve Borene: Everybody wins when they come in and they do it. And the time that they win the most is when they remove the polyp. Yet they are punished for that. And to think of it any other way than punishment gives too much credit to everything else that’s going on here. This is a punishment to people and they suffer for it and they think it was important, and they want to:

Steve Borene: “I want those doctors to get paid for what they did. They just saved my life.” The doctor didn’t make any more. They might have in the big system made an extra little bit, but the system made a whole lot more. The system made more because they got something from you. You don’t owe it to them as a sign of gratitude that they did something helpful for you. It cost them a couple hundred bucks and you’re going to pay them ten thousand bucks. That’s an uneven payback. That goes beyond gratitude or repentance right there. That’s a sick system. That’s a problem.

Andrew Gordon: And I think, too, to distill that really succinctly, too, for people, it’s to say that there are some healthcare prices in this country, in America, that punish people for productive care that ends up serving and improving and giving them the outcomes, quite frankly, that we all desire for ourselves, for our loved ones, for our family.

Andrew Gordon: I want to tell people and help people realize how the Marine and you can adapt and all these other things that you bring together with the pediatric dental case. So you quoted five restorations. It turned out there was going to be nine. You had to call the employer mid case. Tell us about what they said back and how you navigated that situation, because I think a lot of folks will say, hey, there’s some audibles that we got to call. There’s some things that are uncertain about medicine. Fill us in. Tell us about your approach and how you would recommend to other people across the country handle some of these situations.

Steve Borene: I’m glad you brought that up. Yeah, I didn’t have that on my mind. But yeah, so one of the things we do is pediatric dental, it’s something that falls between healthcare and dental care. So it isn’t covered by a lot of people’s dental insurance and it isn’t part of their health plan. So it ends up being a little bit more of a cash pay business in the first place.

Steve Borene: Then you’re dealing with dentists who are better at doing free market business in the first place. So it can be expensive. Those people have to come into the hospital, have a general anesthetic. Now you’ve moved into the medical realm and a hospital has to provide an anesthesiologist and a place to do it. So it gets to be a kind of a murky area.

Steve Borene: We have a pediatric dentist in town who realized what a disadvantage it was for him to have to take patients into the health systems and we connected. So we’ve had a chance to go ahead and really make a difference for people. It’s just a fraction of the cost, but there is a cost to it. And the number of restorations changes, the time, the medication, the materials that he’s using.

Steve Borene: And this one particular patient we had expected would be kind of a smaller case. It ended up being quite a bit more involved. We had a relationship and I almost want to say them out loud because I know that they’ll be watching this at some point. I’m going to go to their open enrollment meeting here in three weeks to meet with a bunch of their employees because they put us front and center and their people can’t wait to come to us.

Steve Borene: But because of that relationship, they trusted us and we called them up and said, hey, this is actually going to cost a bit more. And we prefaced it, said, you don’t have to pay it just so you know this is going to cost more. And because we were wrong, we’re going to lose money on this and it’s going to be, I can’t remember the amount, but it was a few thousand dollars difference in the cost. And we worked with the dentist and told him, you know, we’ll split it with you. We’ll take the cost loss on this case. It hurts a little bit, but we’re helping this patient out. We’ll do that.

Steve Borene: But we let them know. We said, this is not how we’re going to do it. We’re not going to send you the higher bill. But if you’ll consider that higher bill, we’d appreciate it. And we got the thumbs up response in an email. That was it. Thanks. We trust you guys. We know you’re doing what’s best. We appreciate what you’re doing for the patient.

Steve Borene: So we were able to go ahead and set the foundation. We were able to show them who we are, build into being thoughtful and advocates for them. And they knew that when something changed, that we weren’t trying to pull a fast one on them. We weren’t trying to extract anything more. They knew it must have cost more. Something must have changed. And that was it.

Steve Borene: We sent them a bill. We did send a follow up. OK, just so you know, when it comes across, it’s this number instead of that number. And she sent back, yep, that’s what I’m expecting. We sent it over and they paid it. And it was real easy when she said, would you come and speak to us at our open enrollment meeting? Yeah, you bet. Because this is a really worthwhile relationship. Right.

Steve Borene: You know, you build that into healthcare. And I challenge anyone to find that within the legacy system. Find people that will work with you. We would have not added that on if they would have said no. That’s different than what our agreement is. Our agreement is we agree ahead of time and we pay that. We just went asked and we asked because we thought it would be fair. And they thought the same thing.

Steve Borene: And that’s a relationship, you can’t fabricate that. You can’t force that. That comes out of an opportunity to build trust, to go ahead and put each other first. And I wouldn’t ever want to work any other way.

Andrew Gordon: I would say relationships are certainly important. Healthcare has been running on it for many, many decades, for a long, long time. But to take it a step further where you took it, it’s relationships with people that share in your values, with people that are aligning the incentives, with people that you know that you can trust, with people you know that will have your back in a situation where there may be an audible that needs to get called or there might be something.

Andrew Gordon: So you want to have folks, whether we want to chop it up to partners in the supply chain or just partners as part of your everyday operations and what you’re doing that are behind the scenes and in front of the scenes, whatever that may be. But I do think that that’s incredibly important.

Andrew Gordon: I want to shift gears for a moment. I want you to talk about two local surgeons that told you that they were coming. They were going to go up on your website and they were gone within a short period of time. Tell us a little bit about what happened there.

Steve Borene: Within days, yes. So this is the lack of free market, the difficulty of non-compete from restrictive covenants that are put upon especially employed physicians. One of the services that we wanted to open early on in our practice was general surgery. It covers so much and we’ve been doing a great job of that for over a year now.

Steve Borene: But when we first opened, we had a local general surgeon that wanted to come and work with us. And he talked about all the same things that we’ve talked about, all the difficulties in his own practice and things that he was looking, he’d been further along in his career. He wanted to go ahead and do something meaningful. And so we came to an agreement.

Steve Borene: He couldn’t believe that he was going to get this opportunity, but we don’t have enough business to keep someone working full time. We’re a growing business and that’s good. And that means he’s going to have to work in the legacy system still or felt like he had to. He said he wasn’t quite at his retirement point. He still wanted to rely on this other place as a part-time job.

Steve Borene: So he came on. We jumped through all the hoops. He checked his legal requirements. Our distance was far away enough from where his restrictive covenants set up. I feel like it was 25 miles and we were 48 miles away from where he worked and he was going to drive out. We legally looked at it, even had a lawyer look real quick and said, you’re all good.

Steve Borene: But then he came, we put him up on our website. And we got a call the next day. You guys got to take me down off your website. And, you know, that’s crazy. You know, I wonder why he changed his mind. And so we had the conversation.

Steve Borene: His employer, people that worked at a different hospital within the same system, which is located closer to us, noticed his name on there. And they said, wait a minute. Did Dr. So-and-so leave? Thought he worked with us. What’s he doing down there? And it went right up the chain, got right up to a CEO in a hurry.

Steve Borene: And the next thing he knew is he was being threatened, told him he wouldn’t be able to work at both places, that if he was going to go, that he could kiss his retirement goodbye. I reminded him, that’s what they told him, that I think it’s not quite that easy to take a retirement away. But they were going to limit him. And if they had to, they were going to use an injunction to keep him from working there or anywhere else until it got sorted out. Even if he would have won, he would have had to wait during the year or two that it took them to go ahead and get the lawsuit dismissed.

Steve Borene: And they also talked about they have another hospital not far from our location that could be the same one or that he technically has privileges at, and that they could use that as an angle to go ahead and restrict him. So he was off.

Steve Borene: We had another physician that had a very similar, we had already told him, we said, watch out, these people are going to do this. And he said, nope, if you can give me full-time work and guarantee that for the rest of my career, I will quit what I’m doing and I will come and work with you guys. If there isn’t any chance of that, and I mean, who can promise that? If we get hit by a tornado, I mean, I can’t even promise that. So that was the only way. And he was told that by the same mechanism. So we had two physicians that were threatened away.

Steve Borene: I work with a group in Wisconsin that we’re trying to get the legislation changed so that after somebody’s worked with an organization for a couple of years, they can no longer enforce anything like that. But in the state of Wisconsin, that’s still a real active problem. Some states it isn’t a problem at all.

Steve Borene: But these are the ways that physicians are manhandled. And sometimes we have blinders on, other times we have harnesses on to go ahead and keep us from either seeing or thinking independently. Other ones to go ahead and threaten livelihood to keep people away.

Steve Borene: But yeah, that really made things harder. It slowed our growth down by several months. And to be able to find people, to find physicians that are willing to work with us, it takes a bold physician to do that.

Steve Borene: That being said, we have amazing physicians that work within other systems that when those systems said, hey, wait a minute. If you go on the website at Renovo Health, www.renovohealth.care, if you go on that website and we see your picture there, that could have implications here. Every physician we have up on there right now says, that’s fine. Do what you got to do. They have a confidence that the system is going to want to keep them in, working at some point. Some of them have branched off and become their own independent groups as well.

Steve Borene: So it’s been encouraging, but it is really, it was devastating to begin with. And it has slowed us down tremendously just because of that kind of encumbrance that these legacy systems will put on physicians who actually want to practice and think on their own.

Andrew Gordon: It’s a really, really tough area, right. I want to just double click into the magnitude of what you just shared there, where depending on, and culture trickles from the top down, values start from the top down. They spread all throughout an organization. It is concerning that there is leadership out there that would go as far as to threaten somebody’s livelihood and things like that.

Andrew Gordon: I do think though, there’s another side where people will say, well, you know what? I mean, technically that’s a competitor. Technically that’s going to take business away or whatever that may be. What I just heard you describe though, too, is folks are in, physicians and surgeons, people who are thinking about practicing in different areas, sometimes it’s like they’re kind of, it’s a little bit of a gamble, but in trying to figure out who’s going to call somebody else’s bluff out is what it sounds like too, because somebody would be strong or bold enough to say, well, I know that they still need me.

Andrew Gordon: We know that supply numbers in this country are constrained and certainly valued. These surgeons and folks who are practicing and delivering on the front lines are incredibly hard sometimes to retain, hard to find really great people. And so I do think in what you shared, and one of the things that I just want to make sure that folks are realizing is the strength, the value of the people that are making the progress, doing the care delivery, who are on the front lines, who are delivering it, know your value, know your worth, know what you deliver, know how much you make patients happy.

Andrew Gordon: The system is dependent on you. That is the message that I want people to take away from these stories and everything else is know your worth and be able to use that responsibly and accountably. Steve case in point right here with everything that he shared on how he approaches medicine, how he thinks about medicine, how he’s been able to fund and price medicine. These are really important things.

Andrew Gordon: Let’s transition and get into the ending segment here on where this goes. You’ve talked about direct care needing to reach 10% of the market, starting to chip away, get some more market share to make a meaningful impact. How does this transition, how do we enable this to occur? Is it only going to be bold people that are going to end up taking this jump? How do you help people who they might not be as bold, but they want to do this and they feel a little conflicted in their current positions or what’s going on?

Steve Borene: Yeah, I think so much feeds back into your previous statement about value, knowing your own value, right? And that’s true. So the biggest problem with the healthcare system right now isn’t just that it extracts revenue in so many ways, but it extracts value and value, not just in resources, like wealth that we talk about, but also what it takes away from the providers, takes away from the funders of healthcare, the same thing, right? You have less value. So it’s a value extraction device in many ways.

Steve Borene: And what these physicians, these other people that can lead and can actually be doing actionable change, need to realize is it doesn’t necessarily have to be an all or nothing, right? We do have some physicians that are working, if they know their value, they can find a partner. It may not be perfect, but a legacy system where they can still work three days a week or every other week, or they can do locums work. That’s something that Dr. Johnston and I have done, some locums work, where they travel around and do temporary work in different systems. We had done that for years, go ahead and find other places where they can see their value appreciated and then use that extra time. And sometimes it is extra time. I haven’t taken a vacation in, I think it’s two and a half years now, because there’s so much time that needs to be dedicated to moving the market in the way that we’re trying to.

Steve Borene: But not everybody has to go in both feet. You don’t have to go and completely get submerged. We have our pain doctor, for example, still work. She works with us on Saturdays and evenings, which is fine because it fits with her family and her work schedule. There are ways that people can do that.

Steve Borene: We’ve got an independent neurologist who’s just one town over from us, who is the first one in Wisconsin. We’ve got three independent cardiologists in the state that I’m aware of. They’re finding ways, sometimes they’ll accept insurance. So they’ll find a way to bring that in. Our group doesn’t accept insurance directly at all because we don’t want to. We want to stay pure to the ideal and stay as streamlined as we can. But that’s not for everyone.

Steve Borene: One of the cardiologists we work with opened up a single location where he takes insurance. He’s got people in his office that have worked within the health system that way. And his goal is to minimize that. He’s going to start with, he doesn’t take Medicare or Medicaid, but he’s taking insurance. And he’s going to work on that with the idea of diminishing that over the next, I think he said three years. He’s going to try to get rid of a third of that, use two thirds of the practice, fill in with some other people, you know, on cash pay or employers or people that we send over.

Steve Borene: So there are ways to transition. It doesn’t have to be an all or nothing thing. And the benefits that you get, I do think it’s worthwhile to have some, you know, a little bit of a fuller checkbook when you go into doing it, because it can have an effect on the bottom line.

Steve Borene: The benefits that are outside of that are immeasurable. That’s been my experience and my partner’s experience. I can’t imagine ever retiring now. It makes it a lot easier to save for retirement if you’re never going to retire. Right. You know, maybe that’s not the most encouraging thing for people, but we’ve got a passion for what we’re doing. That means we just got to keep doing it and, you know, drop dead at some point and that’ll be brilliant. But until then, I just get to keep doing this. That’s pretty exciting.

Steve Borene: And that’s something I didn’t feel for decades in the legacy system when I worked there, because I would meet with my financial advisor twice a year. How are we looking? Are we sure? What if we got more aggressive here? What if I got a real conservative here? How could we move this up? And all I was doing was counting down to the days.

Steve Borene: And I can’t imagine. I’ve had multiple friends, my wife, my kids, everybody has ever looked at it now and said, yeah, can’t imagine you ever retiring. And I think that’s like the most exciting thing about all of it is we got something we can make a difference with. That’s not something everyone can say, but it’s something that everyone could say if they are in that setting. And I think that’s really worthwhile and shouldn’t be undervalued. Talking of value right there.

Steve Borene: I know my value. I know my value all across the board when it comes to this. I also know that if I got to a position, going back to a point earlier about becoming an expert at something, if I had to go back into the legacy system and make a good living, I could do it. I could pick up the phone and I could get a job today. It’s the middle of the afternoon, late in the week, and I could have a job before the weekend by picking up the phone. And it wouldn’t be gratifying for me. It would never cross my mind.

Steve Borene: But people who leave employed practice or a group, it doesn’t mean you can’t ever go back. If you are somebody that brings value, you will always have something you can step into. And, you know, I think that’s the whole key is to remember that.

Andrew Gordon: Well said. And I do think you have found a labor of love. Those comments were so beautifully put, Steve.

Andrew Gordon: And it’s figuring out, taking an inventory of the current organizations and the roles and the systems that we currently work in, asking ourselves, what are the incentives like talking to folks, spreading it, thinking about from an organizational standpoint, what does that look like? And realizing how important leverage is, leverage that potentially serves and helps us to fill our cup and know our worth and our value versus leverage that may be harming patients. It might be harming employer bank accounts. It may be harming the cost of care in this country and the outcomes that we so desperately deserve at better prices.

Andrew Gordon: And ultimately just comes down to, I don’t think any of us want to be an organization that has any leverage over an ability to compromise our character, our values, what we stand for, the traits that our families and friends know sit within us. That is one of the biggest challenges in modern day healthcare in America.

Andrew Gordon: So thank you so much for that. Who should be reaching out to you? You got employers and brokers and plan sponsors and patients and clinicians. They’ve all gotten a ton of value from this. Are these all types of stakeholders and folks who should contact you?

Steve Borene: Absolutely. Yeah. And thanks for all that. And thanks for the shout out throughout here. Yeah, we have broker partners that have found that their job is easier. They get to actually sell something that benefits their clients.

Steve Borene: We’ve got employers that reach out and sometimes they are located far away. We’ve got one company whose headquarters are in Iowa, but they have a plant in Wisconsin. And so their entire company can come here. And they thought just the Wisconsin-based people would come here. We’ve taken care of more of the people from Iowa that drive up because they see the value. So there’s no advantage to trying to think what your people might think is valuable. If you put something out there that’s a good product, there’s a lot of them that are going to be able to see how it fits for them.

Steve Borene: So I’d say employers, other physicians, we’re glad we’re looking for specialists. If there’s an ENT doc that wants to come and do tonsillectomies and ear tubes with us, we’ve got an open door. We’d like to talk to you. Anyone that’s willing to be accountable to patients and funders. There’s space for all sorts of people here.

Steve Borene: We can give advice. Was just asked yesterday, somebody’s looking to do what we’ve done in Pennsylvania. They’re trying to figure out how they can manage that. Giving them advice. What are some of the pitfalls? What did we do wrong? What have we done right? We just want the conversation to go out there.

Steve Borene: We want anyone who’s got a business that watched their costs go up instead of going down. I’ve seen posts all over. Our costs are going up 12%. Ours went up 20%. I don’t see as many except for the ones that we’re working with. Our costs went down 12%. Companies that we work with, their claims go down 15%. They lower their stop loss exposure for the next year because they know that their costs are going to continue to go down and their premiums are down.

Steve Borene: The broker for that group can sit there and say, wow, I just delivered something really cool. I don’t have to put as much work into them because the work is already going into them. I can find another business. Oh, and I just got a referral from them. This makes it easy.

Steve Borene: This is how it’s going to be in five years, 10 years, somewhere in there. You want to spend the millions in the meantime or you want to start saving the money. You want the higher level care so that when your people are trying to decide whether you’re worth still working for, they stay with you because they got to receive care from us. We’re a great recruitment tool. We’re a great retention tool. We cover all those bases for you. And if you just want to use us for that kind of a tool, we’re happy to be used. We’ve talked about where we fit in. We want to be useful for people in however we can.

Steve Borene: That’s who you should call. Brokers, physicians, people who pay for healthcare, people who receive healthcare. Everybody’s a buyer or seller of healthcare. And most sellers are also still buyers. If you’re anywhere in that group, if you buy healthcare for you or someone else, I bet we can make things better for you. And if we can’t, we can put you in touch with people who can if there’s a geographic barrier.

Steve Borene: But it’s just a matter of identifying what are the barriers to getting the better care and removing them. And turns out that conversation with people who are aligned go a long way.

Andrew Gordon: Beautiful. So on that note, where exactly should they be reaching out, whether it’s an email, LinkedIn, phone number? Feel free to just shout out certain ways.

Steve Borene: You know, I’m on LinkedIn. We have a YouTube page. We have a Facebook page. So those are great places to see some material that we put together. Of course, you know, podcasts like, obviously, what you’re doing.

Steve Borene: www.renovohealth.care, C-A-R-E, is our website. We have a contact us form where people can send a secure email right to us. Everything that we talked about here is going to be right there as well. We’re really easy to reach. Info@renovohealth.care. We’ve also got a phone number, which is listed on the website, 920-273-0562. We’ve got a fax number. It’s all right on the website.

Steve Borene: So that’s the easiest way to do it. And if you can track me down, I’ll answer too. Like you said before, I answer the phone. I’ll do whatever it takes because I want that connection. I prefer when it’s a patient calling with a question saying, hey, I’m supposed to start my bowel prep, but I’ve got this going here or what hotel should I stay at? Or questions like that, because when they come in, I’ve already got them trusting me.

Steve Borene: And that’s so much of what I do as a professional is convince people to trust me, to let me take great care of them. And if I can do that, starting with a phone call ahead of time. I’m way ahead of the game.

Steve Borene: So call us up. Our team is there during most working hours. We’ve got a couple of half days during the week so they can go ahead and recover and recoup. But we look forward to seeing people, any of those means, whether it be answering questions, setting up contracts or seeking care, we’re glad to address all of them.

Andrew Gordon: Well, it’s been an energizing conversation. Steve, thanks so much for coming on the show.

Steve Borene: Well, thanks, Andrew. It’s always a pleasure. Time with you goes by really quickly. Your questions are always so insightful, get me thinking. And you make it real easy to go ahead and talk about something that I find passionate already. So thank you for that. I appreciate all that you do. And we’ll look forward to continuing to benefit together.

Andrew Gordon: I love it. Sounds good. Thank you so much.

Andrew Gordon: And that’s a wrap for this episode of The Price of Healthcare. We’ll see you on the next one. Thanks so much for listening.

The market only works when prices are visible

Join the practitioners, policymakers, and advocates building a transparent healthcare system.

Subscribe to get our monthly newsletter and additional resources.